Employing a Health Care Equity Index to Drive Value Based Care

August 19, 2021

This session will highlight the development of a Health Care Equity Index (HCEI), a tool to help identify opportunities within a health plan, monitor progress towards closure of disparities and help communities and the state meet Health Care Equity goals.

Blue Cross and Blue Shield of North Carolina (Blue Cross NC) sought input and collaboration from a ‘coalition of the willing’ of key stakeholders to address inequities in Blue Cross NC members’ healthcare, and in the state of NC as a whole. This session will highlight the HCEI development process, challenges, and feedback learned. 

Target Audience

  • Health Care Policy Makers  
  • Health Care and Community Leadership  
  • Payors and Providers Seeking Value Based Care

Learning Objectives

  • Assess Race Ethnicity and Language (REL) and Social Determinants of Health data 
  • Develop a Health Care Disparity Index to guide future Value Based Care Payment Models 
  • Strategies for Partnering with Providers, Policy Makers and Community Leaders to Create a "Coalition of Willing" for targeted action to improve Health Care Equity

Click here to access the Quality Innovation Series registration page to register or review the full course content.

Course summary
Course opens: 
Course expires: 
Event starts: 
08/19/2021 - 1:00pm
Event ends: 
08/19/2021 - 2:00pm


Qi Zhou, MD

Qi Zhou is Vice President for Quality and Care Delivery at Blue Cross Blue Shield of North Carolina and is responsible for quality performance, risk adjustment and care delivery program evaluation. Dr. Zhou has over two decades of leadership in quality performance improvement and health informatics. At BCBSMA, he led a cross-functional team responsible for development of a strategy for performance measurement and quality that was central to programs in value-based payment, quality-related product design and consumer engagement. Prior to BCBSMA, Dr. Zhou led performance measurement for physician quality reporting, population health, patient-reported outcomes and member experience at Tufts Health Plan and UPMC Health Plan.

Dr. Zhou also leads efforts in health equity in the community. He is a board member of the Massachusetts Health Data Consortium and is a steering committee member at the Tufts Medical School Division of Clinical Translational Science Research.

Dr. Zhou graduated from Shanghai Medical University School of Medicine, Bryant University Business School and Harvard School of Public Health.


In support of improving patient care, the National Committee for Quality Assurance is jointly accredited for Continuing Medical Education (ACCME), the  American Nurses Credentialing Center (ANCC), the American Academy of Physician Assistants (AAPA), the American Psychological Association (APA), and the Association of Social Work Boards (ASWB) to provide Interprofessional Continuing Education for the healthcare team. 

This educational activity is approved for: 1.0 AMA PRA Category 1 CreditTM and ANA CNE contact hours.*

* Please note – You must attend the entire program to be eligible for total number of contact hours. 


Disclosure of Relevant Financial Relationships:

The National Committee for Quality Assurance (NCQA) endorses the Standards of the Accreditation Council for Continuing Medical Education which specify that sponsors of continuing medical education activities and presenters at and planners for these activities disclose any relevant financial relationships either party might have with commercial companies whose products or services are discussed in educational presentations. 

For sponsors, relevant financial relationships include large research grants, institutional agreements for joint initiatives, substantial gifts, or other relationships that benefit the institution.  For presenters or planning committee members, relevant financial relationships include the receipt of research grants from a commercial company, consultancies, honoraria, travel, or other benefits, or having a self-managed equity interest in a company; or having an immediate family member or partner with such a relationship.

Disclosure of a relationship is not intended to suggest or condone bias in any presentation, but is made to provide participants with information that might be of potential importance to their evaluation of a presentation.

Relevant financial relationships exist with the following companies/organizations:

Name: None
Name: None

Additional Planning Committee Members: 
Name: None

[If conflict(s) exist:] 
Affiliation/Financial Interest        Name of Organization
Name        Grant/Research Support        [Pfizer]
Name         Consultant                [Pfizer, Boehringer Ingelheim, Wyeth]
Name         Speakers’ Bureau            [Pfizer, Boehringer Ingelheim, Sanofi Aventis]
Major Stockholder/Shareholder        [McKesson]
Other Financial or Material Support    [None]
(note: just put in what’s relevant) 

[If conflicts exist:] Program content was peer reviewed to ensure that it is fair-balanced and free from commercial bias.



Please login or register to take this course.